PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
11-Oct-2023 Veterinary Electrosurgery Industry Poised for 7% CAGR, Surpassing US$ 993.41 Million by 2032 | FMI MARKITWIRED
11-Oct-2023 Elastography Imaging Industry Surges with 11.2% CAGR, Predicted to Hit US$8.9 Billion by 2032 | FMI Insights MARKITWIRED
11-Oct-2023 Transdermal Drug Delivery Systems Market Growing at 4.9% CAGR, Set to Reach USD 87.32 Billion By 2030, Exclusive Report The Wire Times
11-Oct-2023 Global Adult Vaccines Market Research Report 2023: Market to Surpass $25 Billion by 2027 - Long-term Forecasts to 2032 - ResearchAndMarkets.com Businesswire
11-Oct-2023 FMI Report Discloses the 7.18% CAGR Surge, Predicting US$ 10.96 Billion Valuation for Medical Device Analytical Testing Outsourcing by 2032 MARKITWIRED
11-Oct-2023 Neurovascular Devices and Interventional Neurology Industry on Track for an Astounding US$6.2 Billion Market by 2032 at 8.5% CAGR | FMI MARKITWIRED
11-Oct-2023 AI in Genomics Market Trends 2023: Predicted to Surpass USD 9.8 Billion by the year 2031 | CAGR of 40.6% The Wire Times
11-Oct-2023 2cureX advances towards IVD-R compliance by securing a contract with a Notified Body 2cureX
11-Oct-2023 The PolG Foundation awards over $3.5M in academic grants to pioneer POLG research PolG Foundation
11-Oct-2023 PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting PureTech
11-Oct-2023 eXmoor completes expansion into full-service cell and gene therapy CDMO partner with opening of GMP facilities eXmoor pharma
11-Oct-2023 EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition EVERSANA
11-Oct-2023 Almirall's Ilumetri® (tildrakizumab) significantly improves wellbeing for patients1 and their relatives2 in moderate-to-severe plaque psoriasis Almirall S.A.
11-Oct-2023 Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark Mainz BioMed N.V.
11-Oct-2023 AM-Pharma Announces Positive Clinical Data From Phase 1b Study Evaluating Ilofotase Alfa in Hypophosphatasia Patients Businesswire
11-Oct-2023 The PolG Foundation Awards Over $3.5M in Academic Grants to Pioneer POLG Research B3C newswire
11-Oct-2023 Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The Oxford Science Park to Accelerate Development of its Immuno-Oncology and ADC-Based Cancer Therapies Oxford BioTherapeutics
11-Oct-2023 ANALYSIS LINKS INFLAMMATORY BIOMARKER TO NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD), REINFORCES EFFICACY OF UPLIZNA® (INEBILIZUMAB) IN REDUCING DISEASE-RELATED ATTACKS Amgen
11-Oct-2023 Biocomposites announces new territories approved to promote STIMULAN as an antibiotic carrier in bone and soft tissue Biocomposites
11-Oct-2023 Cytovation Reports Promising Interim Results from Phase 1/2a CICILIA Study with CyPep-1 in Solid Tumors Cytovation ASA